Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Brad Adams"'
Autor:
Sara A. Hurvitz, Jennifer L. Caswell-Jin, Katherine L. McNamara, Jason J. Zoeller, Gregory R. Bean, Robert Dichmann, Alejandra Perez, Ravindranath Patel, Lee Zehngebot, Heather Allen, Linda Bosserman, Brian DiCarlo, April Kennedy, Armando Giuliano, Carmen Calfa, David Molthrop, Aruna Mani, Hsiao-Wang Chen, Judy Dering, Brad Adams, Eran Kotler, Michael F. Press, Joan S. Brugge, Christina Curtis, Dennis J. Slamon
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
HER2+ breast cancer patients can often develop resistance to trastuzumab and therefore potential combination therapies need to be explored. Here, the authors report the results of a multi-center randomized phase II clinical trial evaluating the patho
Externí odkaz:
https://doaj.org/article/3ed71c9a08f44623be4704bf23a0df55
Autor:
Parvin F. Peddi, Merry Tetef, Paul Coluzzi, Karo K. Arzoo, Eddie H. Hu, Maurice J. Berkowitz, David Chan, Dennis Moore, Brad Adams, Xiaoyan Wang, Sara A. Hurvitz
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Stomatitis is a frequent dose limiting toxicity of everolimus, an approved therapy for patients with metastatic breast cancer. No randomized trials of a prophylactic measure to prevent mucositis have been reported. Methods: We conducted a
Externí odkaz:
https://doaj.org/article/75c6ea8cccd543f2944ff91e58816f0f
Autor:
Sara Hurvitz, Rashi Singh, Brad Adams, Julie A. Taguchi, David Chan, Robert A. Dichmann, Aurelio Castrellon, Eddie Hu, Jonathan Berkowitz, Aruna Mani, Brian DiCarlo, Rena Callahan, Ira Smalberg, Xiaoyan Wang, Ivana Meglar, Diego Martinez, Evthokia Hobbs, Dennis J. Slamon
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 10 (2018)
Background: Improving outcomes for patients with human epidermal growth factor 2-positive (HER2+) central nervous system (CNS) metastases remains an unmet clinical need. This trial evaluated a novel combination of everolimus, lapatinib and capecitabi
Externí odkaz:
https://doaj.org/article/ab3ff30b785f4020af0ccd8527133e15
Autor:
Rodney Murillo Peixoto Couto, Elvis Almeida Pereira, Daniel Bühler, Maiara Cabrera Miguel, Guilherme Brad Adams, Fernanda Dias-Silva
Publikováno v:
Acta Biológica Colombiana, Vol 26, Iss 2 (2021)
Acta Biológica Colombiana, Volume: 26, Issue: 2, Pages: 273-277, Published: 18 JAN 2022
Acta Biológica Colombiana, Volume: 26, Issue: 2, Pages: 273-277, Published: 18 JAN 2022
Although predatory events are uncommon to be recorded in nature, these data are important tools for understanding prey-predator interaction of the involved species. Snakes of genus Thamnodynastes are known for having an anuran diet, including some sp
Autor:
Judy Dering, Linda D. Bosserman, Alejandra T. Perez, Christina Curtis, Jason J. Zoeller, Sara A. Hurvitz, Dennis J. Slamon, Ravindranath Patel, Gregory R. Bean, April Kennedy, Katherine McNamara, B DiCarlo, R Dichmann, Aruna Mani, Armando E. Giuliano, Eran Kotler, Joan S. Brugge, Carmen Calfa, Michael F. Press, Heather Allen, Hsiao Wang Chen, David Molthrop, Jennifer L. Caswell-Jin, Brad Adams, Lee Zehngebot
Publikováno v:
Nature communications, vol 11, iss 1
Nature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
Nature Communications
In this multicenter, open-label, randomized phase II investigator-sponsored neoadjuvant trial with funding provided by Sanofi and GlaxoSmithKline (TRIO-US B07, Clinical Trials NCT00769470), participants with early-stage HER2-positive breast cancer (N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c071057d28a2c930749fdb77e63c624
https://escholarship.org/uc/item/5fs667t3
https://escholarship.org/uc/item/5fs667t3
Autor:
Craig Sussman, James H. Nichols, Brad Adams, Joesph R Wiencek, Alison Woodworth, Gregory Sephel, MacRae F. Linton, Christopher Bowman
Publikováno v:
The Journal of Applied Laboratory Medicine. 2:123-125
To the Editor: Lipemia is a complex interferant in clinical laboratory testing (1). Turbidity caused by increased VLDL and chylomicrons scatters light in spectrophotometric-based methods (2, 3). To address this issue, analyzer and reagent manufacture
Publikováno v:
Check List, Vol 13, Iss 3, Pp 1-3 (2017)
We present new records for Hydrodynastes melanogigas Franco, Fernandes & Bentim, 2007, from eastern Mato Grosso state, Central Brazil. The four specimens found in the municipalities of Novo Santo Antônio and Ribeirão Cascalheira represent the first
Autor:
Jill M. Siegfried, Eddie H. Hu, Rupesh J. Parikh, David J. Park, Saeed Sadeghi, Robert Elashoff, Brad Adams, Laura P. Stabile, Simon Davenport, Tristan Grogan, Edward B. Garon, Ravi Patel, David Elashoff, Karen L. Reckamp, Yacgley Valdes, Meghan Brennan, Diana C. Márquez-Garbán, Steven M. Dubinett, Michael F. Press, He-Jing Wang, Dennis J. Slamon, Sanja Dacic, Patricia A. Young, Richard J. Pietras
Objectives This open-label, randomized phase II trial evaluated antitumor efficacy of an antiestrogen, fulvestrant, in combination with human epidermal growth factor receptor (EGFR) inhibitor, erlotinib, in advanced non-small cell lung cancer (NSCLC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc76ec0cf7c17c9340d54ffa3912f106
https://europepmc.org/articles/PMC6118115/
https://europepmc.org/articles/PMC6118115/
Autor:
Ivana Meglar, Rena Callahan, Eddie H. Hu, Xiaoyan Wang, Aurelio Castrellon, Dennis J. Slamon, Jonathan Berkowitz, B DiCarlo, Rashi Singh, R Dichmann, Brad Adams, Aruna Mani, Ira S. Smalberg, Julie Taguchi, Diego Martinez, Evthokia A Hobbs, David Chan, Sara A. Hurvitz
Publikováno v:
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 10 (2018)
Therapeutic Advances in Medical Oncology, Vol 10 (2018)
Background:Improving outcomes for patients with human epidermal growth factor 2-positive (HER2+) central nervous system (CNS) metastases remains an unmet clinical need. This trial evaluated a novel combination of everolimus, lapatinib and capecitabin
Autor:
Brad Adams, W. Lawler, D. Melancon, Jonathan W. Goldman, B. Telivala, Fadi Braiteh, Dorothy S. Martinez, Edward B. Garon, Benjamin P Jones, B DiCarlo, Xiaoyan Wang, Zorawar S. Noor, K. Kennedy
Publikováno v:
Journal of Thoracic Oncology. 13:S813-S814